Report describes primary clear cell sarcoma of head, neck

Report describes primary clear cell sarcoma of head, neck

(HealthDay)—Three cases of primary clear cell sarcoma of the head and neck have been described in three male patients, according to a review published online June 6 in the Journal of Cutaneous Pathology.

Patrick C. Feasel, M.D., from the Cleveland Clinic, and colleagues reported three cases of molecularly confirmed primary head and neck clear cell sarcoma, with no primary elsewhere.

The researchers found that the tumors presented on the scalp of a 33-year-old man, the face of a 20-year-old man, and the tongue of a 44-year-old . The tumors ranged in size from 0.6 to 1.4 cm. Typical features of clear cell sarcoma, including nests of cells divided by fibrous septae, were seen in all tumors, while one had multinucleated wreath-like giant cells and one had a focal junctional component. All three tumors had immunohistochemistry for S100 and HMB45, and two had immunohistochemistry for Melan-A. By fluorescence in situ hybridization, all had EWSR1 rearrangements. In one patient, follow-up showed no evidence of disease after wide excision and radiation. Seven additional cases were identified on review of the literature.

"Head and clear cell sarcoma is rare but should be considered in the differential diagnosis of nested tumors with fibrous septae," the authors write. "Molecular analysis should be considered for definitive diagnosis regardless of location."


Explore further

MED15 involved in head and neck squamous cell carcinoma

More information: Abstract
Full Text (subscription or payment may be required)

Copyright © 2016 HealthDay. All rights reserved.

Citation: Report describes primary clear cell sarcoma of head, neck (2016, June 13) retrieved 15 October 2019 from https://medicalxpress.com/news/2016-06-primary-cell-sarcoma-neck.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
0 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more